Further investigations into the role of NSD1, NSD2, and NSD3 in the context of HPV-negative and HPV-positive HNSCC are critical for a deeper understanding of the function of these promising therapeutic targets in the pathogenesis of HNSCC. This evidence concerns the gene NSD3 and head and neck squamous cell carcinoma.